Search Results for " Leniolisib "
Leniolisib Related Products
Leniolisib is a medication used to treat a genetic disorder that weakens the immune system, specifically caused by a mutation associated with activated PI3K delta syndrome (APDS). It is the first drug approved for managing this condition and has been designated by the U.S. Food and Drug Administration (FDA) as a first-in-class treatment.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Leniolisib, pharmacopeial and non-pharmacopeial Leniolisib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Leniolisib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Leniolisib-related products are thoroughly characterized. Leniolisib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.